References
1. Kusne S, Mooney M, Danziger-Isakov L, et al. An ISHLT consensus document for prevention and management strategies for mechanical circulatory support infection. J Heart Lung Transplant . 2017;36(10):1137-1153. doi:10.1016/j.healun.2017.06.007
2. Wilsey HA, Burgess DR, Burgess DS. Focusing the Lens on the CAMERA Concepts: Early Combination β-Lactam and Vancomycin Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia. Antimicrob Agents Chemother . 2020;64(7):e00360-20. doi:10.1128/AAC.00360-20
3. Cardenas-Alvarez JL, Suarez J, Motoa G, et al. Cefazolin plus ertapenem and heart transplantation as salvage therapy for refractory LVAD infection due to methicillin-susceptible Staphylococcus aureus: A case series. J Card Surg . 2021;36(12):4786-4788. doi:10.1111/jocs.16040
4. Ulloa ER, Singh KV, Geriak M, et al. Cefazolin and Ertapenem Salvage Therapy Rapidly Clears Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia. Clin Infect Dis Off Publ Infect Dis Soc Am . 2019;71(6):1413-1418. doi:10.1093/cid/ciz995
5. Sakoulas G, Olson J, Yim J, Singh NB, Kumaraswamy M, Quach DT, Rybak MJ, Pogliano J, Nizet V. Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus Bacteremia. Antimicrob Agents Chemother. 2016 Oct 21;60(11):6609-6618. doi: 10.1128/AAC.01192-16.
6. Hannan MM, Husain S, Mattner F, et al. Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. J Heart Lung Transplant . 2011;30(4):375-384. doi:10.1016/j.healun.2011.01.717
7. Qu Y, Peleg AY, McGiffin D. Ventricular Assist Device-Specific Infections. J Clin Med . 2021;10(3):453. doi:10.3390/jcm10030453
8. El-Dalati S, Sridaran S, Uricchio M, Kline EG, Shields R. Oxacillin plus ertapenem combination therapy leads to rapid blood culture clearance and positive outcomes among patients with persistent MSSA bacteraemia: a case series. JAC-Antimicrob Resist . 2021;3(3):dlab148. doi:10.1093/jacamr/dlab148
9. Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study - ScienceDirect. Accessed January 5, 2022. https://www.sciencedirect.com/science/article/pii/S1473309920304473?via%3Dihub